Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 0.60 |
| ▸ | MAOA | P21397 | 10/20 | 0.60 |
| ▸ | PARP1 | P09874 | 4/20 | 0.58 |
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.58 |
| ▸ | F7 | P08709 | 1/20 | 0.58 |
| ▸ | F3 | P13726 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 5/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29098025 | 1.00 | MAOB (0.60) | MAOBMAOAPARP1PARP10F7 | |
| SCHEMBL1037269 | 0.82 | DRD2 (0.56) | PARP1PARP10F7F3DRD2 | |
| SCHEMBL1038435 | 0.81 | DRD2 (0.57) | PARP1PARP10F7F3DRD2 | |
| SCHEMBL29097994 | 0.78 | HRH3 (0.56) | MAOBMAOA | |
| SCHEMBL247155 | 0.78 | PARP10 (0.54) | PARP1PARP10F7F3DRD2 | |
| SCHEMBL3397008 | 0.77 | DRD2 (0.53) | PARP1PARP10F7F3DRD2 | |
| SCHEMBL29676942 | 0.75 | PARP10 (1.00) | PARP1PARP10F7F3 | |
| SCHEMBL793493 | 0.75 | PARP10 (1.00) | PARP1PARP10F7F3 | |
| SCHEMBL31444064 | 0.74 | MAOA (0.64) | MAOBMAOAPARP1PARP10F7 | |
| SCHEMBL5106942 | 0.73 | HRH3 (0.70) | MAOBMAOADRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594669-B | Parallel ring derivative and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-115594669-A | Fused ring derivative and preparation method and medical application thereof | 深圳信立泰药业股份有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |